↓ Skip to main content

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment

Overview of attention for article published in Frontiers in oncology, September 2023
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
2 Mendeley